Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-24-097741
Filing Date
2024-08-16
Accepted
2024-08-15 19:12:04
Documents
13
Period of Report
2024-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A nktx-20240813.htm   iXBRL 8-K/A 48430
2 EX-99.1 nktx-ex99_1.htm EX-99.1 121231
3 GRAPHIC img220989892_0.jpg GRAPHIC 17177
  Complete submission text file 0000950170-24-097741.txt   325483

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nktx-20240813.xsd EX-101.SCH 27140
15 EXTRACTED XBRL INSTANCE DOCUMENT nktx-20240813_htm.xml XML 5570
Mailing Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080 (925) 407-1049
Nkarta, Inc. (Filer) CIK: 0001787400 (see all company filings)

EIN.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39370 | Film No.: 241213792
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)